$1.22
0.064.74%
Last update: 1:32 PM
15 minutes delayed
Comments
Loading...
Chemomab Therapeutics
CMMBNASDAQ
Chemomab Therapeutics (NASDAQ:CMMB) Stock, Earnings Estimates, EPS, And Revenue
Chemomab Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 9
EPS
$-0.280
Quarterly Revenue
$0K
Annual Revenue
(as of Mar 31)
(as of Mar 31)
–
Analyze the earnings history of Chemomab Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CMMB | Chemomab Therapeutics | -$0.72 | — | — | — | $0.00 | — | — | — | 08/12/2024 | Get Alert |
| CMMB | Chemomab Therapeutics | -$0.80 | — | -$0.28 | — | $0.00 | — | $0.00 | — | 05/09/2024 | Get Alert |
| CMMB | Chemomab Therapeutics | -$0.72 | — | -$0.26 | — | $0.00 | — | $0.00 | — | 03/07/2024 | Get Alert |
| CMMB | Chemomab Therapeutics | -$0.70 | -$0.02 | -$0.34 | -1600.00% | $0.00 | — | $0.00 | — | 11/09/2023 | Get Alert |
| CMMB | Chemomab Therapeutics | -$0.54 | -$0.80 | -$0.72 | 10.00% | $0.00 | — | $0.00 | — | 08/14/2023 | Get Alert |
| CMMB | Chemomab Therapeutics | -$0.02 | -$0.03 | -$0.80 | -2566.67% | $0.00 | — | $0.00 | — | 05/11/2023 | Get Alert |
| CMMB | Chemomab Therapeutics | -$0.44 | — | -$0.72 | — | $0.00 | — | $0.00 | — | 03/30/2023 | Get Alert |
| CMMB | Chemomab Therapeutics | -$0.26 | -$0.33 | -$0.70 | -112.12% | $0.00 | — | $0.00 | — | 11/11/2022 | Get Alert |
| CMMB | Chemomab Therapeutics | -$0.26 | -$0.25 | -$0.54 | -116.00% | $0.00 | — | $0.00 | — | 08/12/2022 | Get Alert |
| CMMB | Chemomab Therapeutics | -$0.22 | -$0.24 | -$0.02 | 90.83% | $0.00 | — | $0.00 | — | 05/12/2022 | Get Alert |
| CMMB | Chemomab Therapeutics | -$0.01 | -$0.10 | -$0.44 | -340.00% | $0.00 | — | $0.00 | — | 03/09/2022 | Get Alert |
| CMMB | Chemomab Therapeutics | $0.01 | -$0.14 | -$0.26 | -85.71% | $0.00 | — | $0.00 | — | 11/12/2021 | Get Alert |
| CMMB | Chemomab Therapeutics | -$0.01 | -$0.11 | -$0.26 | -136.36% | — | — | $0.00 | — | 08/13/2021 | Get Alert |
| CMMB | Chemomab Therapeutics | — | -$0.34 | -$0.22 | 35.29% | — | — | $0.00 | — | 05/13/2021 | Get Alert |
Chemomab Therapeutics (CMMB) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Sep 2023 | 2023-11-09 | $-0.34 | $-0.02 | -1600.0 % |
| Jun 2023 | 2023-08-14 | $-0.72 | $-0.80 | 10.0 % |
| Mar 2023 | 2023-05-11 | $-0.80 | $-0.03 | -2566.7 % |
| Sep 2022 | 2022-11-11 | $-0.70 | $-0.33 | -112.1 % |
Chemomab Therapeutics (CMMB) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Chemomab Therapeutics (NASDAQ:CMMB) reporting earnings?
Chemomab Therapeutics (CMMB) is scheduled to report earnings on August 12, 2024. The last reported earnings were for reported on May 9, 2024 for Q1.
What were the latest earnings per share (EPS) for Chemomab Therapeutics (NASDAQ:CMMB)?
The Actual EPS was $-0.28, which missed the estimate of $0.00.
What were Chemomab Therapeutics’s (NASDAQ:CMMB) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.